Harmony Biosciences Holdings Dirección
Dirección controles de criterios 3/4
Actualmente no disponemos de información suficiente sobre el CEO.
Información clave
Jeffrey Dayno
Chief Executive Officer (CEO)
US$4.5m
Compensación total
| Porcentaje del salario del CEO | 13.8% |
| Permanencia del CEO | 1.8yrs |
| Participación del CEO | n/a |
| Permanencia media de la dirección | 3.8yrs |
| Promedio de permanencia en la Junta Directiva | 4.3yrs |
Actualizaciones recientes de la dirección
Recent updates
Harmony Biosciences: sNDA Of WAKIX Brings Additional Value Inflection Points
Nov 11Harmony Biosciences Holdings, Inc. Just Recorded A 19% EPS Beat: Here's What Analysts Are Forecasting Next
Oct 31
Is Harmony Biosciences Holdings (NASDAQ:HRMY) Using Too Much Debt?
Oct 30Many Still Looking Away From Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
Sep 25Harmony Biosciences: Advancing An Expanded Pipeline
Aug 15Harmony Biosciences Holdings (NASDAQ:HRMY) Has A Rock Solid Balance Sheet
Jul 15Investors Holding Back On Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
Jun 07Harmony Biosciences Holdings, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
May 03These 4 Measures Indicate That Harmony Biosciences Holdings (NASDAQ:HRMY) Is Using Debt Safely
Apr 04Market Cool On Harmony Biosciences Holdings, Inc.'s (NASDAQ:HRMY) Earnings
Feb 09Fewer Investors Than Expected Jumping On Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
Mar 21Does Harmony Biosciences Holdings (NASDAQ:HRMY) Deserve A Spot On Your Watchlist?
Dec 01Harmony Biosciences: In Harmony
Sep 23We Ran A Stock Scan For Earnings Growth And Harmony Biosciences Holdings (NASDAQ:HRMY) Passed With Ease
Aug 05Harmony Biosciences Non-GAAP EPS of $0.57 misses by $0.06, revenue of $107M beats by $6.25M
Aug 02Harmony Biosciences: Steady Revenue Generator Looking For A Future
May 26Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$123m |
| Jun 30 2024 | n/a | n/a | US$115m |
| Mar 31 2024 | n/a | n/a | US$138m |
| Dec 31 2023 | US$4m | US$613k | US$129m |
| Sep 30 2023 | n/a | n/a | US$151m |
| Jun 30 2023 | n/a | n/a | US$200m |
| Mar 31 2023 | n/a | n/a | US$189m |
| Dec 31 2022 | US$762k | US$459k | US$181m |
| Sep 30 2022 | n/a | n/a | US$156m |
| Jun 30 2022 | n/a | n/a | US$58m |
| Mar 31 2022 | n/a | n/a | US$49m |
| Dec 31 2021 | US$703k | US$446k | US$35m |
| Sep 30 2021 | n/a | n/a | US$12m |
| Jun 30 2021 | n/a | n/a | US$17m |
| Mar 31 2021 | n/a | n/a | -US$7m |
| Dec 31 2020 | US$3m | US$431k | -US$64m |
| Sep 30 2020 | n/a | n/a | -US$110m |
| Jun 30 2020 | n/a | n/a | -US$146m |
| Mar 31 2020 | n/a | n/a | -US$165m |
| Dec 31 2019 | US$672k | US$414k | -US$187m |
Compensación vs. Mercado: La compensación total ($USD4.45M) de Jeffrey está en línea con el promedio de empresas de tamaño similar en el mercado US ($USD5.34M).
Compensación vs. Ingresos: La compensación de Jeffrey ha aumentado más de un 20%, mientras que los beneficios de la empresa han caído más de un 20% en el último año.
CEO
Jeffrey Dayno (67 yo)
1.8yrs
Permanencia
US$4,450,294
Compensación
Dr. Jeffrey M. Dayno, M.D. serves as President, Chief Executive Officer and Director at Harmony Biosciences, LLC since 2023 and served as its Interim President and Chief Executive Officer since January 06,...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Founder & Non-Executive Chairman | 7.1yrs | US$185.67k | 0.44% $ 8.4m | |
| President | 1.8yrs | US$4.45m | sin datos | |
| Executive VP | 3.7yrs | US$5.58m | 0.049% $ 928.2k | |
| Executive VP and Chief Medical & Scientific Officer | less than a year | US$760.81k | 0.0018% $ 33.3k | |
| Executive VP & Chief Commercial Officer | 6.3yrs | US$5.60m | 0% $ 0 | |
| Executive VP & Chief Strategy Officer | 5.9yrs | US$647.43k | 0% $ 0 | |
| Head of Technical Operations | no data | sin datos | sin datos | |
| VP & Head of Investor Relations | no data | sin datos | sin datos | |
| General Counsel & Corporate Secretary | 3.8yrs | sin datos | sin datos | |
| Chief Compliance Officer | 3.5yrs | sin datos | sin datos | |
| Vice Presidet of Human Resources | no data | sin datos | sin datos | |
| Head of Corporate Affairs & Public Policy | no data | sin datos | sin datos |
3.8yrs
Permanencia media
54yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de HRMY se considera experimentado (3.8 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Founder & Non-Executive Chairman | 7.1yrs | US$185.67k | 0.44% $ 8.4m | |
| President | 1.8yrs | US$4.45m | sin datos | |
| Independent Director | 7.2yrs | sin datos | sin datos | |
| Independent Director | 4yrs | US$179.99k | 0% $ 0 | |
| Independent Director | 4.3yrs | US$303.00k | 0% $ 0 | |
| Independent Director | 7.2yrs | US$235.00k | 0% $ 0 | |
| Independent Director | less than a year | US$132.51k | sin datos | |
| Independent Director | 3yrs | US$174.99k | 0% $ 0 | |
| Independent Director | 7.8yrs | US$179.99k | 0% $ 0 |
4.3yrs
Permanencia media
59yo
Promedio de edad
Junta con experiencia: La junta directiva de HRMY se considera experimentada (4.3 años de antigüedad promedio).